Mental Health & Addiction (MHA)

PI-025 - PATIENT PROFILES OF OPIOID USE DISORDER PATIENTS TREATED WITH ORAL VERSUS MONTHLY INJECTABLE BUPRENORPHINE USING U.S. REAL-WORLD MEDICAID CLAIMS DATA.

PII-024 - CHARACTERIZING METHADONE:METABOLITE RATIO DURING METHADONE INDUCTION IN PREGNANCY

PII-025 - THE POTENTIAL OF SMARTWATCH-DERIVED CARDIAC MEASUREMENTS AS BIOMARKERS OF THERAPEUTIC RESPONSE IN CHILDREN WITH DISRUPTIVE BEHAVIOR DISORDER